Studies further detected the expression of CD34 in isolated cancer stem cells of leukemia, colorectal cancer, brain tumors, and head and neck cancer, which indicates a potential of CD34 as a surface marker of tumor stem cells. This evidence concerns the gene CD34 and colorectal cancer.